Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothea Bankwitz

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|April 26, 2017
Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivityDorothea Bankwitz, Mandy Doepke, Kathrin Hueging, et al.
Journal of Virology|August 22, 2014
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteinsDorothea Bankwitz, Gabrielle Vieyres, Kathrin Hueging, et al.
Journal of Virology|November 11, 2011
Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitopeMarianne Ruhl, Patrick Chhatwal, Heiko Strathmann, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoproteinSandra Westhaus, Dorothea Bankwitz, Stefanie Ernst, et al.
Journal of Virology|April 2, 2010
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopesDorothea Bankwitz, Eike Steinmann, Julia Bitzegeio, et al.
Plos One|July 12, 2014
Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodiesMilena Lange, Melanie Fiedler, Dorothea Bankwitz, et al.
Mbio|May 18, 2017
Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2Ieva Vasiliauskaite, Ania Owsianka, Patrick England, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsKoen Vercauteren, Naomi Van Den Eede, Ahmed Atef Mesalam, et al.
Gut|December 16, 2020
Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodiesDorothea Bankwitz, Akash Bahai, Maurice Labuhn, et al.
Gut|August 2, 2013
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cellsAnggakusuma, Che C Colpitts, Luis M Schang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|April 26, 2017
Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivityDorothea Bankwitz, Mandy Doepke, Kathrin Hueging, et al.
Journal of Virology|August 22, 2014
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteinsDorothea Bankwitz, Gabrielle Vieyres, Kathrin Hueging, et al.
Journal of Virology|November 11, 2011
Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitopeMarianne Ruhl, Patrick Chhatwal, Heiko Strathmann, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoproteinSandra Westhaus, Dorothea Bankwitz, Stefanie Ernst, et al.
Journal of Virology|April 2, 2010
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopesDorothea Bankwitz, Eike Steinmann, Julia Bitzegeio, et al.
Plos One|July 12, 2014
Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodiesMilena Lange, Melanie Fiedler, Dorothea Bankwitz, et al.
Mbio|May 18, 2017
Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2Ieva Vasiliauskaite, Ania Owsianka, Patrick England, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsKoen Vercauteren, Naomi Van Den Eede, Ahmed Atef Mesalam, et al.
Gut|December 16, 2020
Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodiesDorothea Bankwitz, Akash Bahai, Maurice Labuhn, et al.
Gut|August 2, 2013
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cellsAnggakusuma, Che C Colpitts, Luis M Schang, et al.
Pageof 3